Erman Akkus, Medical Oncology Fellow at Ankara University, shared an article by C. Valenza, et al. on X:
“Can ctDNA clearance predict pCR in neoadjuvant IO?
– Sensitivity 0.98, but
– Specificity 0.53
Should not rely on ctDNA clearance to inform treatment decisions.”
Authors: C. Valenza et al.
